-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Novartis Oncology AMACO Regional Marketing Director Pu Cunxia announced to employees that Novartis Oncology (China) General Manager Alexandre Gibim will be transferred to Novartis's AAA platform as the head of North America, effective from January 1, 2022
On March 1, 2019, Alexandre Gibim, the then President of Novartis (Brazil), was transferred to the General Manager of Novartis Oncology (China), and he had the Chinese name "Ji Bicheng".
Ji Bicheng’s successor has been determined.
Isabel Afonso graduated from the University of Minho in Portugal with a degree in computer science engineering.
After that, Isabel Afonso left Novartis in August 2018 to join Performance Health, a rehabilitation and sports medicine product company, and served as the Chief Commercial Officer of Performance Health since last year
In April of this year, Isabel Afonso returned to Novartis again as the head of Novartis Oncology (China) Strategy and Portfolio Management Department.
BeiGene's National Head of Blood Tumor Sales Resigns
BeiGene's National Head of Blood Tumor Sales ResignsAlso today, the Human Resources Department of BeiGene announced to employees that the national head of blood and tumor sales, Yi Hao, will leave the company on November 15, 2021 to seek external development opportunities
According to Dami’s understanding, the current successor has not yet been determined.